Revvity signals software unveils signals clinical solution to accelerate critical clinical trial insights and data-driven decisions

Waltham, mass.--(business wire)--today, revvity, inc. (nyse: rvty) announced that its software and informatics division, revvity signals, is unveiling the signals clinicaltm solution, a software-as-a-service (saas), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics. this state-of-the-art solution, when integrated with enterprise-class spotfir.
RVTY Ratings Summary
RVTY Quant Ranking